Blood plasma and parasite drug: hunt for Covid cure

Among the contenders in the race to beat Covid-19 is a drug traditionally used against parasites such as worms – and the use of blood plasma from recovered patients.

The first idea is being led by MedinCell, a pharma firm based near Montpellier, Hérault.

Plasma trials are being done by AP-HP (Assistance Publique – Hôpitaux de Paris), Europe’s largest teaching hospital group.

The well-known safe anti-parasite drug ...

To read the remaining 85% of this article, you need to either

Subscribe now to The Connexion and benefit from access to our archived articles since 2006

Print + Digital 3 month subscription

Pay every three months. Our most flexible subscription.

Automatic renewal, cancel anytime

€14.25 to France - €18 to EU/UK - €19.50 to rest of the world per quarter including postage

Print + Digital 1 year subscription

1 year of great reading in print and online

Automatic renewal, cancel anytime

€55 to France - €70 to EU/UK - €76 to rest of the world per year including postage

Digital 1 year subscription (Our best value offer)

1 year of great reading online *no paper*

Automatic renewal, cancel anytime

Digital 3 month subscription

3 months of great reading online *no paper*

Automatic renewal, cancel anytime

More articles from Health
More articles from Connexion France
Other articles that may interest you